---
figid: PMC2839263__bph0159-1051-f2
figlink: /pmc/articles/PMC2839263/figure/fig02/
number: Figure 2
caption: Emerging models for the role of β-arrestin in wingless (from Drosophila)
  and the oncogene int-1 (WNT) signalling. WNT-induced and Fizzled (FZD)-mediated
  signalling through β-catenin-dependent and -independent pathway requires β-arrestin
  and its interaction with Dishevelled (DVL). (A) In non-canonical WNT/RAC-1 and WNT/RHO
  pathways, recruitment of WNT/FZD/DVL complexes to clathrin-coated pits is mediated
  through β-arrestin interaction with adaptin/clathrin. Receptor tyrosine kinase RYK
  (RYK) is necessary for internalization and translocation of the complex to early
  endosomes. Translocation decreases cell surface numbers of FZDs and could contribute
  to desensitization of WNT/FZD signalling. In addition, signalling endosomes could
  contribute to specificity and compartmentation. (B) In the WNT/β-catenin pathway,
  β-arrestin promotes WNT-induced phosphorylation of DVL and increases binding between
  axin and DVL. This probably happens in the context of the ‘signalosome’ derived
  from lipid rafts. It is not clear whether β-arrestin serves only as a scaffolding
  protein or whether β-arrestin-dependent endocytosis is required. (C) WNT-directed
  signalling through the atypical receptor tyrosine kinases of the ROR family, phosphatidylinositol-3'-kinase,
  the small GTPase CDC42, c-JUN N-terminal kinase, paraxial protocadherin (PAPC) and
  subsequent modulation of convergent extension appears to be β-arrestin independent.
  (C′) Indirect experimental evidence suggests that the WNT/RAS-related protein 1,
  RAS proximate (RAP1) pathway involving casein kinase 1ε (CK1ε) could be β-arrestin
  independent. PAR1, partitioning defective mutant in C. elegans; PKC, protein kinase
  C; LRP5/6, lipoprotein-related protein5/6; ROR2, receptor tyrosine kinase ROR2.
pmcid: PMC2839263
papertitle: β-arrestins – scaffolds and signalling elements essential for WNT/Frizzled
  signalling pathways?.
reftext: Gunnar Schulte, et al. Br J Pharmacol. 2010 Mar;159(5):1051-1058.
pmc_ranked_result_index: '41223'
pathway_score: 0.952776
filename: bph0159-1051-f2.jpg
figtitle: Emerging models for the role of Beta-arrestin in wingless (from Drosophila)
  and the oncogene int-1 (WNT) signalling
year: '2010'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2839263__bph0159-1051-f2.html
  '@type': Dataset
  description: Emerging models for the role of β-arrestin in wingless (from Drosophila)
    and the oncogene int-1 (WNT) signalling. WNT-induced and Fizzled (FZD)-mediated
    signalling through β-catenin-dependent and -independent pathway requires β-arrestin
    and its interaction with Dishevelled (DVL). (A) In non-canonical WNT/RAC-1 and
    WNT/RHO pathways, recruitment of WNT/FZD/DVL complexes to clathrin-coated pits
    is mediated through β-arrestin interaction with adaptin/clathrin. Receptor tyrosine
    kinase RYK (RYK) is necessary for internalization and translocation of the complex
    to early endosomes. Translocation decreases cell surface numbers of FZDs and could
    contribute to desensitization of WNT/FZD signalling. In addition, signalling endosomes
    could contribute to specificity and compartmentation. (B) In the WNT/β-catenin
    pathway, β-arrestin promotes WNT-induced phosphorylation of DVL and increases
    binding between axin and DVL. This probably happens in the context of the ‘signalosome’
    derived from lipid rafts. It is not clear whether β-arrestin serves only as a
    scaffolding protein or whether β-arrestin-dependent endocytosis is required. (C)
    WNT-directed signalling through the atypical receptor tyrosine kinases of the
    ROR family, phosphatidylinositol-3'-kinase, the small GTPase CDC42, c-JUN N-terminal
    kinase, paraxial protocadherin (PAPC) and subsequent modulation of convergent
    extension appears to be β-arrestin independent. (C′) Indirect experimental evidence
    suggests that the WNT/RAS-related protein 1, RAS proximate (RAP1) pathway involving
    casein kinase 1ε (CK1ε) could be β-arrestin independent. PAR1, partitioning defective
    mutant in C. elegans; PKC, protein kinase C; LRP5/6, lipoprotein-related protein5/6;
    ROR2, receptor tyrosine kinase ROR2.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PRKD3
  - PRKCH
  - WNT4
  - PRKCB
  - DVL2
  - DVL3
  - LRP6
  - FZD4
  - WNT5B
  - CTNNB1
  - LRP5
  - WNT8A
  - WNT3A
  - AXIN2
  - DVL1
  - WNT10A
  - WNT5A
  - PRKCA
  - WNT16
  - CDC42
  - FZD8
  - FZD9
  - WNT10B
  - FZD3
  - FZD1
  - PRKCG
  - WNT2
  - WNT7A
  - PRKCI
  - PRKCQ
  - WNT8B
  - FZD10
  - PRKCD
  - PRKCE
  - WNT9A
  - WNT6
  - FZD2
  - FZD5
  - AXIN1
  - WNT11
  - WNT9B
  - WNT1
  - WNT3
  - RHOA
  - RAC1
  - FZD6
  - FZD7
  - RYK
  - TERF2IP
  - ROR2
  - WNT2B
  - WNT7B
  - PRKCZ
  - Cancer
genes:
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT4
  entrez: '54361'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: DVL
  symbol: DVL
  source: bioentities_symbol
  hgnc_symbol: DVL2
  entrez: '1856'
- word: DVL
  symbol: DVL
  source: bioentities_symbol
  hgnc_symbol: DVL3
  entrez: '1857'
- word: LRP5/6
  symbol: LRP6
  source: hgnc_symbol
  hgnc_symbol: LRP6
  entrez: '4040'
- word: FZD
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD4
  entrez: '8322'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5B
  entrez: '81029'
- word: B-catenin
  symbol: beta-catenin
  source: hgnc_alias_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: LRP5/6
  symbol: LRP5
  source: hgnc_symbol
  hgnc_symbol: LRP5
  entrez: '4041'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8A
  entrez: '7478'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3A
  entrez: '89780'
- word: axin
  symbol: AXIN
  source: bioentities_symbol
  hgnc_symbol: AXIN2
  entrez: '8313'
- word: DVL
  symbol: DVL
  source: bioentities_symbol
  hgnc_symbol: DVL1
  entrez: '1855'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10A
  entrez: '80326'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5A
  entrez: '7474'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT16
  entrez: '51384'
- word: CDC42
  symbol: CDC42
  source: hgnc_symbol
  hgnc_symbol: CDC42
  entrez: '998'
- word: FZD
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD8
  entrez: '8325'
- word: FZD
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD9
  entrez: '8326'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10B
  entrez: '7480'
- word: FZD
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD3
  entrez: '7976'
- word: FZD
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD1
  entrez: '8321'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2
  entrez: '7472'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7A
  entrez: '7476'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8B
  entrez: '7479'
- word: FZD
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD10
  entrez: '11211'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9A
  entrez: '7483'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT6
  entrez: '7475'
- word: FZD
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD2
  entrez: '2535'
- word: FZD
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD5
  entrez: '7855'
- word: axin
  symbol: AXIN
  source: bioentities_symbol
  hgnc_symbol: AXIN1
  entrez: '8312'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT11
  entrez: '7481'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9B
  entrez: '7484'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT1
  entrez: '7471'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3
  entrez: '7473'
- word: signallingtoRAC-1/RHO-A
  symbol: RHOA
  source: hgnc_symbol
  hgnc_symbol: RHOA
  entrez: '387'
- word: RAC-1/RHO-A
  symbol: Rac-1
  source: hgnc_alias_symbol
  hgnc_symbol: RAC1
  entrez: '5879'
- word: FZD
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD6
  entrez: '8323'
- word: FZD
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD7
  entrez: '8324'
- word: RYK
  symbol: RYK
  source: hgnc_symbol
  hgnc_symbol: RYK
  entrez: '6259'
- word: RAP1
  symbol: RAP1
  source: hgnc_alias_symbol
  hgnc_symbol: TERF2IP
  entrez: '54386'
- word: ROR2
  symbol: ROR2
  source: hgnc_symbol
  hgnc_symbol: ROR2
  entrez: '4920'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2B
  entrez: '7482'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7B
  entrez: '7477'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
---
